{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:13:37Z","timestamp":1747152817926,"version":"3.40.5"},"publisher-location":"New York, NY","reference-count":50,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071636282"},{"type":"electronic","value":"9781071636299"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3629-9_20","type":"book-chapter","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:01:51Z","timestamp":1711004511000},"page":"361-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer\u2019s Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2514-1654","authenticated-orcid":false,"given":"Katharina","family":"Schindowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.conb.2015.09.004","volume":"36","author":"L Kr\u00fcger","year":"2015","unstructured":"Kr\u00fcger L, Mandelkow EM (2015) Tau neurotoxicity and rescue in animal models of human Tauopathies. Curr Opin Neurobiol 36:52\u201358","journal-title":"Curr Opin Neurobiol"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","volume":"7S1","author":"K Schindowski","year":"2008","unstructured":"Schindowski K, Belarbi K, Buee L (2008) Neurotrophic factors in Alzheimer\u2019s disease: role of axonal transport. Genes Brain Behav 7S1:43\u201356","journal-title":"Genes Brain Behav"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","volume":"24","author":"MV Sofroniew","year":"2001","unstructured":"Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217\u20131281","journal-title":"Annu Rev Neurosci"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev-physchem-032511-143704","volume":"63","author":"PD Chowdary","year":"2012","unstructured":"Chowdary PD, Che DL, Cui B (2012) Neurotrophin signaling via long-distance axonal transport. Annu Rev Phys Chem 63:571\u2013594","journal-title":"Annu Rev Phys Chem"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0165-0173(00)00030-8","volume":"33","author":"GJ Siegel","year":"2000","unstructured":"Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s disease brain. Brain Res Brain Res Rev 33:199\u2013227","journal-title":"Brain Res Brain Res Rev"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0306-4522(98)00219-X","volume":"88","author":"MG Murer","year":"1999","unstructured":"Murer MG, Boissiere F, Yan Q, Hunot S, Villares J, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R (1999) An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer\u2019s disease. Neuroscience 88:1015\u20131032","journal-title":"Neuroscience"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555\u2013563","journal-title":"Behav Brain Res"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0169-328X(03)00003-2","volume":"111","author":"B Michalski","year":"2003","unstructured":"Michalski B, Fahnestock M (2003) Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer\u2019s disease. Brain Res Mol Brain Res 111:148\u2013154","journal-title":"Brain Res Mol Brain Res"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1046\/j.1471-4159.2002.01030.x","volume":"82","author":"D Garzon","year":"2002","unstructured":"Garzon D, Yu G, Fahnestock M (2002) A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer\u2019s disease parietal cortex. J Neurochem 82:1058\u20131064","journal-title":"J Neurochem"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/archneur.57.6.846","volume":"57","author":"C Hock","year":"2000","unstructured":"Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846\u2013851","journal-title":"Arch Neurol"},{"key":"20_CR11","first-page":"85","volume":"387","author":"M Goedert","year":"1986","unstructured":"Goedert M, Fine A, Hunt SP, Ullrich A (1986) Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer\u2019s disease. Brain Res 387:85\u201392","journal-title":"Brain Res"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1523\/JNEUROSCI.15-09-06213.1995","volume":"15","author":"SA Scott","year":"1995","unstructured":"Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA (1995) Nerve growth factor in Alzheimer\u2019s disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15:6213\u20136221","journal-title":"J Neurosci"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00005072-199907000-00007","volume":"58","author":"I Ferrer","year":"1998","unstructured":"Ferrer I, Mar\u00edn C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Mart\u00ed E (1998) BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58:729\u2013739","journal-title":"J Neuropathol Exp Neurol"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0896-6273(00)80140-3","volume":"16","author":"SL Patterson","year":"1996","unstructured":"Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16:1137\u20131145","journal-title":"Neuron"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.neurobiolaging.2013.08.029","volume":"35","author":"JC Belrose","year":"2014","unstructured":"Belrose JC, Masoudi R, Michalski B, Fahnestock M (2014) Increased pro\u2013nerve growth factor and decreased brain-derived neurotrophic factor in non\u2013Alzheimer\u2019s disease tauopathies. Neurobiol Aging 35:926\u2013933","journal-title":"Neurobiol Aging"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2353\/ajpath.2006.060002","volume":"169","author":"K Schindowski","year":"2006","unstructured":"Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M, Buee L (2006) Alzheimer\u2019s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169:599\u2013616","journal-title":"Am J Pathol"},{"key":"20_CR17","first-page":"1543","volume":"33","author":"H Hideo","year":"2009","unstructured":"Hideo H, Keiko T, Nobuyuki Y, Tsuyoshi M (2009) Dissection of hippocampal dentate gyrus from adult mouse. J Vis Exp 33:1543","journal-title":"J Vis Exp"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jim.2005.04.018","volume":"302","author":"KM Keays","year":"2005","unstructured":"Keays KM, Owens GP, Ritchie AM, Gilden DH, Burgoon MP (2005) Laser capture microdissection and single-cell RT-PCR without RNA purification. J Immunol Methods 302:90\u201398","journal-title":"J Immunol Methods"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0014-4886(90)90068-4","volume":"109","author":"C Wetmore","year":"1990","unstructured":"Wetmore C, Ernfors P, Persson H, Olson L (1990) Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol 109:141\u2013152","journal-title":"Exp Neurol"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0925-4773(97)00135-4","volume":"68","author":"U Ernsberger","year":"1997","unstructured":"Ernsberger U, Patzke H, Rohrer H (1997) The developmental expression of choline acetyltransferase (ChAT) and the neuropeptide VIP in chick sympathetic neurons: evidence for different regulatory events in cholinergic differentiation. Mech Dev 68:115\u2013126","journal-title":"Mech Dev"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.modgep.2006.03.009","volume":"6","author":"MJ Webster","year":"2006","unstructured":"Webster MJ, Herman MM, Kleinman JE, Weickert CS (2006) BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns 6:941\u2013951","journal-title":"Gene Expr Patterns"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","volume":"15","author":"M Nibuya","year":"1995","unstructured":"Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539\u20137547","journal-title":"J Neurosci"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2006.09.069","volume":"410","author":"MR Micheli","year":"2006","unstructured":"Micheli MR, Bova R, Laurenzi MA, Bazzucchi M, Zucconi GG (2006) Modulation of BDNF and TrkB expression in rat hippocampus in response to acute neurotoxicity by diethyldithiocarbamate. Neurosci Lett 410:66\u201370","journal-title":"Neurosci Lett"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuron.2008.06.023","volume":"59","author":"Y Li","year":"2008","unstructured":"Li Y, Luikart BW, Birnbaum S, Chen J, Kwon CH, Kernie SG, Bassel-Duby R, Parada LF (2008) TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59:399\u2013412","journal-title":"Neuron"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","volume":"15","author":"MA Smith","year":"1995","unstructured":"Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15:1768\u20131777","journal-title":"J Neurosci"},{"key":"20_CR26","first-page":"S560","volume":"7","author":"K Schindowski","year":"2011","unstructured":"Schindowski K (2011) Decreased axonal transport during Alzheimer\u2019s-like spatial-temporal tau pathology leads to imbalance of NGF, cholinergic dysfunction, and decreased regulation of BDNF and TrkB. Alzheimers Dement 7:S560\u2013S561","journal-title":"Alzheimers Dement"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1460-9568.2005.04290.x","volume":"22","author":"E Elliott","year":"2005","unstructured":"Elliott E, Atlas R, Lange A, Ginzburg I (2005) Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism. Eur J Neurosci 22:1081\u20131089","journal-title":"Eur J Neurosci"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1101\/lm.2606","volume":"13","author":"R Hellweg","year":"2006","unstructured":"Hellweg R, Lohmann P, Huber R, Kuhl A, Riepe MW (2006) Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment. Learn Mem 13:63\u201371","journal-title":"Learn Mem"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1523\/JNEUROSCI.5599-03.2004","volume":"24","author":"GJ Burbach","year":"2004","unstructured":"Burbach GJ, Hellweg R, Haas CA, Del Turco D, Deicke U, Abramowski D, Jucker M, Staufenbiel M, Deller T (2004) Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J Neurosci 24:2421\u20132430","journal-title":"J Neurosci"},{"key":"20_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1601-183X.2007.00377.x","volume":"7S1","author":"K Schindowski","year":"2008","unstructured":"Schindowski K, Belarbi K, Bretteville A, Ando K, Bu\u00e9e L (2008) Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation. Genes Brain Behav 7S1:92\u2013100","journal-title":"Genes Brain Behav"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/NEN.0b013e3181aed9e6","volume":"68","author":"MA Bruno","year":"2009","unstructured":"Bruno MA, Leon WC, Fragoso G, Mushynski WE, Almazan G, Cuello AC (2009) Amyloid \u03b2-induced nerve growth factor dysmetabolism in Alzheimer disease. J Neuropathol Exp Neurol 68:857\u2013869","journal-title":"J Neuropathol Exp Neurol"},{"key":"20_CR32","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/jnr.20996","volume":"84","author":"ET Saez","year":"2006","unstructured":"Saez ET, Pehar M, Vargas MR, Barbeito L, Maccioni RB (2006) Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75(NTR)-dependent tau hyperphosphorylation in cultured hippocampal neurons. J Neurosci Res 84:1098\u20131106","journal-title":"J Neurosci Res"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1242\/jcs.01018","volume":"117","author":"Y Tatebayashi","year":"2004","unstructured":"Tatebayashi Y, Haque N, Tung YC, Iqbal K, Grundke-Iqbal I (2004) Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport. J Cell Sci 117:1653\u20131663","journal-title":"J Cell Sci"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/jnen\/63.6.641","volume":"63","author":"S Peng","year":"2004","unstructured":"Peng S, Wuu J, Mufson EJ, Fahnestock M (2004) Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63:641\u2013649","journal-title":"J Neuropathol Exp Neurol"},{"key":"20_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1006\/mcne.2001.1016","volume":"18","author":"M Fahnestock","year":"2001","unstructured":"Fahnestock M, Michalski B, Xu B, Coughlin MD (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer\u2019s disease. Mol Cell Neurosci 18:210\u2013220","journal-title":"Mol Cell Neurosci"},{"key":"20_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/mcne.2002.1163","volume":"21","author":"S Capsoni","year":"2002","unstructured":"Capsoni S, Giannotta S, Cattaneo A (2002) Beta-amyloid plaques in a model for sporadic Alzheimer\u2019s disease based on transgenic anti-nerve growth factor antibodies. Mol Cell Neurosci 21:15\u201328","journal-title":"Mol Cell Neurosci"},{"key":"20_CR37","doi-asserted-by":"publisher","first-page":"13089","DOI":"10.1523\/JNEUROSCI.0457-10.2010","volume":"30","author":"G Houeland","year":"2010","unstructured":"Houeland G, Romani A, Marchetti C, Amato G, Capsoni S, Cattaneo A, Marie H (2010) Transgenic mice with chronic NGF deprivation and Alzheimer\u2019s disease-like pathology display hippocampal region-specific impairments in short-and long-term plasticities. J Neurosci 30:13089\u201313094","journal-title":"J Neurosci"},{"key":"20_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2174\/187152711796235032","volume":"10","author":"S Capsoni","year":"2011","unstructured":"Capsoni S, Brandi R, Arisi I, D\u2019Onofrio M, Cattaneo A (2011) A dual mechanism linking NGF\/proNGF imbalance and early inflammation to Alzheimer\u2019s disease neurodegeneration in the AD11 anti-NGF mouse model. CNS Neurol Disord Drug Targets 10:635\u2013647","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"20_CR39","doi-asserted-by":"publisher","first-page":"10439","DOI":"10.1073\/pnas.181219298","volume":"98","author":"JD Cooper","year":"2001","unstructured":"Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC (2001) Failed retrograde transport of NGF in a mouse model of Down\u2019s syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 98:10439\u201310444","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.expneurol.2004.11.017","volume":"193","author":"H Seo","year":"2005","unstructured":"Seo H, Isacson O (2005) Abnormal APP, cholinergic and cognitive function in Ts65Dn Down\u2019s model mice. Exp Neurol 193:469\u2013480","journal-title":"Exp Neurol"},{"key":"20_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0168-0102(03)00005-1","volume":"45","author":"CL Hunter","year":"2003","unstructured":"Hunter CL, Isacson O, Nelson M, Bimonte-Nelson H, Seo H, Lin L, Ford K, Kindy MS, Granholm AC (2003) Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down\u2019s syndrome. Neurosci Res 45:437\u2013445","journal-title":"Neurosci Res"},{"key":"20_CR42","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.neurobiolaging.2003.10.010","volume":"25","author":"CL Hunter","year":"2004","unstructured":"Hunter CL, Bimonte-Nelson HA, Nelson M, Eckman CB, Granholm AC (2004) Behavioral and neurobiological markers of Alzheimer\u2019s disease in Ts65Dn mice: effects of estrogen. Neurobiol Aging 25:873\u2013884","journal-title":"Neurobiol Aging"},{"key":"20_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","volume":"51","author":"A Salehi","year":"2006","unstructured":"Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC (2006) Increased APP expression in a mouse model of Down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51:29\u201342","journal-title":"Neuron"},{"key":"20_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm1239","volume":"11","author":"MH Tuszynski","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M, Salmon DP, Hoi Sang U, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551\u2013555","journal-title":"Nat Med"},{"key":"20_CR45","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","volume":"72","author":"MH Tuszynski","year":"2015","unstructured":"Tuszynski MH, Yang JH, Barba D, Hoi Sang U, Bakay RA, Pay MM, Masliah E, Conner JM, Kobalka P, Roy S, Nagahara AH (2015) Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease. JAMA Neurol 72:1139\u20131147","journal-title":"JAMA Neurol"},{"key":"20_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nrneurol.2015.170","volume":"11","author":"H Malkki","year":"2015","unstructured":"Malkki H (2015) NGF gene therapy activates neurons in the AD patient brain. Nat Rev Neurol 11:548","journal-title":"Nat Rev Neurol"},{"key":"20_CR47","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11033-021-06968-9","volume":"49","author":"A Nasrolahi","year":"2022","unstructured":"Nasrolahi A, Javaherforooshzadeh F, Jafarzadeh-Gharehziaaddin M, Mahmoudi J, Asl KD, Shabani Z (2022) Therapeutic potential of neurotrophic factors in Alzheimer\u2019s disease. Mol Biol Rep 49:2345\u20132357","journal-title":"Mol Biol Rep"},{"key":"20_CR48","volume-title":"Recent advances in NGF and related molecules: the continuum of the NGF \u201cSaga\u201d","author":"S Mitra","year":"2021","unstructured":"Mitra S, Gera R, Linderoth B, Lind G, Wahlberg L, Almqvist P, Behbahani H, Eriksdotter M (2021) A review of techniques for biodelivery of nerve growth factor (NGF) to the brain in relation to Alzheimer\u2019s disease. In: Calz\u00e0 L, Aloe L, Giardino L (eds) Recent advances in NGF and related molecules: the continuum of the NGF \u201cSaga\u201d. Springer International Publishing, Cham"},{"key":"20_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao L, Zhang Y, Sterling K, Song W (2022) Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener 11:4","journal-title":"Transl Neurodegener"},{"key":"20_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2019.07.018","volume":"84","author":"A Shekari","year":"2019","unstructured":"Shekari A, Fahnestock M (2019) Retrograde axonal transport of BDNF and proNGF diminishes with age in basal forebrain cholinergic neurons. Neurobiol Aging 84:131\u2013140","journal-title":"Neurobiol Aging"}],"container-title":["Methods in Molecular Biology","Tau Protein"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3629-9_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:03:39Z","timestamp":1711004619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3629-9_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071636282","9781071636299"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3629-9_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"22 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}